Klinische Forschung
Achtung: Diese Seite kann nur von Administratoren besucht werden, da Sie nicht freigeschalten wurde.
Publications Navarini Alexander

Anonymous automated counselling for aesthetic dermatology using a chatbot - an analysis of age- and gender-specific usage patterns.

Feuchter S; Kunz M; Djamei V; Navarini AA. Journal of the European Academy of Dermatology and Venereology : JEADV. 2021.

Canakinumab Lacks Efficacy in Treating Adult Patients with Moderate to Severe Chronic Spontaneous Urticaria in a Phase II Randomized Double-Blind Placebo-Controlled Single-Center Study.

Maul JT; Distler M; Kolios A; Maul LV; Guillet C; Graf N; Imhof L; Lang C; Navarini AA; Schmid-Grendelmeier P. The journal of allergy and clinical immunology. In practice. 2021.

Gender differences in psoriasis: a Swiss online psoriasis survey.

Murer C; Sgier D; Mettler SK; Guillet C; Maul JT; Djamei V; Navarini AA; Anzengruber F. ARCHIVES OF DERMATOLOGICAL RESEARCH. 2021.

Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome.

Hasan Ali O; Yurchenko AA; Pavlova O; Sartori A; Bomze D; Higgins R; Ring SS; Hartmann F; Bühler D; Fritzsche FR; Jochum W; Navarini AA; Kim A; French LE; Dermitzakis E; Christiano AM; Hohl D; Bickers DR; Nikolaev SI; Flatz L. Journal of the European Academy of Dermatology and Venereology : JEADV. 2021.

Mucosal side effects in patients treated with topical imiquimod-A scoping review of the literature.

Hammerl V; Parlar B; Navarini A; Gantenbein L; Väth H; Mueller SM. Dermatologic therapy. 2021.

National publication productivity in dermatology: an exploratory analysis of contributing factors.

Gantenbein L; Navarini A; Brandt O; Mueller SM. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2021.

Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)

Steeb T.; Wessely A.; Alter M.; Bayerl C.; Bender A.; Bruning G.; Dabrowski E.; Debus D.; Devereux N.; Dippel E.; Drexler K.; Ducker P.; Dummer R.; Emmert S.; Elsner P.; Enk A.; Gebhardt C.; Gesierich A.; Goebeler M.; Goerdt S.; Goetze S.; Gutzmer R.; Haferkamp S.; Hansel G.; Hassel J.C.; Heinzerling L.; Kahler K.C.; Kaume K.M.; Krapf W.; Kreuzberg N.; Lehmann P.; Livingstone E.; Loffler H.; Loquai C.; Mauch C.; Mangana J.; Meier F.; Meissner M.; Moritz R.K.C.; Maul L.V.; Muller V.; Mohr P.; Navarini A.; Van Nguyen A.; Pfeiffer C.; Pfohler C.; Posch C.; Richtig E.; Rompel R.; Sachse M.M.; Sauder S.; Schadendorf D.; Schatton K.; Schulze H.-J.; Schultz E.; Schilling B.; Schmuth M.; Simon J.C.; Streit M.; Terheyden P.; Thiem A.; Tuting T.; Welzel J.; Weyandt G.; Wesselmann U.; Wollina U.; Ziemer M.; Zimmer L.; Zutt M.; Berking C.; Schlaak M.; Heppt M.V.. Journal of cancer research and clinical oncology. 2021.

Proposition of a severity scale for lichen sclerosus: The "Clinical Lichen Sclerosus Score".

Erni B; Navarini AA; Huang D; Schoetzau A; Kind A; Mueller SM. Dermatologic therapy. 2021.

Scrotal erythema and geographic tongue subsequent to multikinase inhibiting therapy with Pazopanib

Gerber F.; Jungo P.; Navarini A.A.; Vasconcelos-Berg R.. Dermatologic therapy. 2021.

Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway.

Maul JT; Anzengruber F; Conrad C; Cozzio A; Häusermann P; Jalili A; Kolios AGA; Laffitte E; Lapointe AK; Mainetti C; Schlapbach C; Trüeb R; Yawalkar N; Dippel M; Navarini AA. . 2021.

Applications of generative adversarial networks to dermatologic imaging

Furger F.; Amruthalingam L.; Navarini A.; Pouly M.. . 2020.

Artificial intelligence—it depends on what we make of it Künstliche Intelligenz – Es kommt darauf an, was wir daraus machen

Kaufmann R.; Navarini A.. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 2020.

Artificial intelligence to support telemedicine in Africa Künstliche Intelligenz zur Unterstützung der Telemedizin am Beispiel Afrikas

Greis C.; Maul L.V.; Hsu C.; Djamei V.; Schmid-Grendelmeier P.; Navarini A.A.. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 2020.

Association of clinical and demographic factors with the severity of palmoplantar pustulosis

Benzian-Olsson N.; Dand N.; Chaloner C.; Bata-Csorgo Z.; Borroni R.; David Burden A.; Cooper H.L.; Cornelius V.; Cro S.; Dasandi T.; Griffiths C.E.M.; Kingo K.; Koks S.; Lachmann H.; McAteer H.; Meynell F.; Mrowietz U.; Parslew R.; Patel P.; Pink A.E.; Reynolds N.J.; Tanew A.; Torz K.; Trattner H.; Wahie S.; Warren R.B.; Wright A.; Barker J.N.; Navarini A.A.; Smith C.H.; Capon F.. JAMA dermatology. 2020.

Contagious itch and disgust during a lecture on ectoparasitic infestations: Two co-activated complementary parasite defense systems?

Kamber MS; Sutter M; Navarini A; Mueller SM. Dermatologic therapy. 2020.

Co-Occurrence of ANCA-Associated Vasculitis and Sjögren's Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients.

Fuchs PS; Lötscher J; Berkemeier CM; Hirsiger JR; Ghosh A; Li QZ; Deigendesch N; Christ E; Navarini AA; Recher M; Daikeler T; Heijnen IAFM; Berger CT. Frontiers in Immunology. 2020.

Critical incidence reporting in dermatology: a cross-sectional study of 94 cases in a tertiary referral center.

Mueller SM; Mohr G; Navarini AA; Gantenbein L; Goldust M; Karagaiah P; Schwendimann R. . 2020.

Dermatology and specialty rotations: COVID-19 may reemphasize the importance of internal medicine.

Goldust M; Sharma A; Murrell DF; Kazemi N; Rudnicka L; Kassir M; Navarini A; Mueller SM. . 2020.

Efficacy of Omalizumab in Mastocytosis: Allusive Indication Obtained from a Prospective, Double-Blind, Multicenter Study (XOLMA Study).

Distler M; Maul JT; Steiner UC; Jandus P; Kolios AGA; Murer C; Graf N; Seebach JD; Pichler WJ; Navarini AA; French LE; Helbling A; Schmid-Grendelmeier P. Dermatology (Basel, Switzerland). 2020.

Fever with rash in COVID-19: viral exanthema or secondary lesions?

Goldust M; Abdelmaksoud A; Shuang Z; Xiang C; Navarini AA. . 2020.

Fiction, Falsehoods, and Few Facts: Cross-Sectional Study on the Content-Related Quality of Atopic Eczema-Related Videos on YouTube.

Mueller SM; Hongler VNS; Jungo P; Cajacob L; Schwegler S; Steveling EH; Manjaly Thomas ZR; Fuchs O; Navarini A; Scherer K; Brandt O. Journal of Medical Internet Research. 2020.

Global Trends in YouTube and Google Search Activity for Psoriasis and Atopic Eczema: Detecting Geographic Hot Spots, Blind Spots and Treatment Strategies.

Hongler VNS; Navarini A; Brandt O; Goldust M; Mueller SM. Dermatologic therapy. 2020.

Hand disinfection in the combat against COVID-19.

Goldust M; Abdelmaksoud A; Navarini AA. . 2020.

IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes.

Satoh TK; Mellett M; Meier-Schiesser B; Fenini G; Otsuka A; Beer HD; Rordorf T; Maul JT; Hafner J; Navarini AA; Contassot E; French LE. The Journal of clinical investigation. 2020.

Imaging photothermal-induced expansion of bone during laser osteotomy by phase-sensitive OCT: Preliminary results

Hamidi A.; Bayhaqi Y.A.; Canbaz F.; Navarini A.; Cattin P.C.; Zam A.. . 2020.

Internet and social media use in dermatology patients: Search behavior and impact on patient-physician relationship.

Gantenbein L; Navarini AA; Maul LV; Brandt O; Mueller SM. Dermatologic therapy. 2020.

Levocetirizine for the treatment of itch in psoriasis patients: An open-label pilot study in a real-world setting.

Mueller SM; Navarini AA; Goldust M; Brandt O; Griffiths CEM; Kleyn CE. Dermatologic therapy. 2020.

Loss-of-Function Myeloperoxidase Mutations Are Associated with Increased Neutrophil Counts and Pustular Skin Disease

Vergnano M.; Mockenhaupt M.; Benzian-Olsson N.; Paulmann M.; Grys K.; Mahil S.K.; Chaloner C.; Barbosa I.A.; August S.; Burden A.D.; Choon S.-E.; Cooper H.; Navarini A.A.; Reynolds N.; Wahie S.; Warren R.B.; Wright A.; Abraham T.; Ali M.; Baudry D.; Bewley A.; Ingram J.; Kelly S.; Korshid M.; Ladoyanni E.; McKenna J.; Meynell F.; Parslew R.; Patel P.; Pushparajah A.; Reynolds N.; Smith C.; Warren R.; Huffmeier U.; Baum P.; Visvanathan S.; Barker J.N.; Smith C.H.; Capon F.. American Journal of Human Genetics. 2020.

National Publication Productivity during the COVID-19 Pandemic-A Preliminary Exploratory Analysis of the 30 Countries Most Affected.

Müller SM; Mueller GF; Navarini AA; Brandt O. BIOLOGY. 2020.

Observer-independent assessment of psoriasis-affected area using machine learning.

Meienberger N; Anzengruber F; Amruthalingam L; Christen R; Koller T; Maul JT; Pouly M; Djamei V; Navarini AA. Journal of the European Academy of Dermatology and Venereology : JEADV. 2020.

Pain reduction by dehydrated human amnion/chorion membrane allograft in nondiabetic leg ulcers might be an early indicator of good response: A case series.

Mueller SM; Navarini AA; Itin P; Schwegler S; Laeuchli S; Goldust M; Ivanova K. Dermatologic therapy. 2020.

Pathophysiology of autoinflammatory dermatoses Pathophysiologie der autoinflammatorischen Dermatosen

Feldmeyer L.; Navarini A.A.. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 2020.

Performing dermoscopy in the COVID-19 pandemic.

Goldust M; Zalaudek I; Gupta A; Lallas A; Rudnicka L; Navarini AA. . 2020.

Pitfall prayer marks: Recognition and appropriate treatment: A case report and review of literature.

Fosse N; Rast AC; Kammermann A; Sonderegger J; Navarini A; Goldust M; Brandt O; Mueller SM. Dermatologic therapy. 2020.

Pruritic and antipruritic colors: An exploratory pilot study.

Mueller SM; Carruthers HR; Navarini AA; Goldust M; Gysin S; Itin PH. Dermatologic therapy. 2020.

Review of biologics in allergic contact dermatitis.

Bhatia J; Sarin A; Wollina U; Lotti T; Navarini AA; Mueller SM; Grabbe S; Saloga J; Rokni GR; Goldust M. Contact Dermatitis. 2020.

Safety of the current drug treatments for vitiligo.

Lotti T; Agarwal K; Podder I; Satolli F; Kassir M; Schwartz RA; Wollina U; Grabbe S; Navarini AA; Mueller SM; Goldust M. Expert opinion on drug safety. 2020.

SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report

Jamiolkowski D.; Muhleisen B.; Muller S.; Navarini A.A.; Tzankov A.; Roider E.. Lancet (London, England). 2020.

Sexually transmitted coinfections in patients with anogenital warts - a retrospective analysis of 196 patients.

Mueller SM; Menzi S; Kind AB; Blaich A; Bayer M; Navarini A; Itin P; Brandt O. JDDG - Journal of the German Society of Dermatology. 2020.

Sexuell übertragbare Koinfektionen bei Patienten mit anogenitalen Warzen - eine retrospektive Analyse von 196 Patienten.

Mueller SM; Menzi S; Kind AB; Blaich A; Bayer M; Navarini A; Itin P; Brandt O. JDDG - Journal of the German Society of Dermatology. 2020.

Skin cancer and COVID-19.

Goldust M; Agarwal K; Podder I; Navarini AA. . 2020.

Skin Recovery After Discontinuation of Long-Term Moisturizer Application: A Split-Face Comparison Pilot Study

Maul J.-T.; Maul L.V.; Kagi M.; Cheng P.; Anzengruber F.; von Laue M.; Chen Y.; Kagi M.; Navarini A.. Dermatology and Therapy. 2020.

Smart identification of psoriasis by images using convolutional neural networks: a case study in China.

Zhao S; Xie B; Li Y; Zhao X; Kuang Y; Su J; He X; Wu X; Fan W; Huang K; Su J; Peng Y; Navarini AA; Huang W; Chen X. Journal of the European Academy of Dermatology and Venereology : JEADV. 2020.

Temporär gestielte nasolabiale Schwenklappenplastik mit Flügeln zur Rekonstruktion kombinierter Nasenspitzen-Columella-Defekte.

Volz A; Häusermann P; Navarini AA; Volz T. JDDG - Journal of the German Society of Dermatology. 2020.

The association between smoking and risk of skin cancer: a meta-analysis of cohort studies

Arafa A.; Mostafa A.; Navarini A.A.; Dong J.-Y.. CANCER CAUSES & CONTROL. 2020.

The first mention of itch in history? When Egyptologists scratch their heads.

Mueller SM; Gantenbein L; Navarini A; Ständer S; Jacob A; Popko L. Journal of the European Academy of Dermatology and Venereology : JEADV. 2020.

The relationship between PASI and DLQI with itch, stress, and depression: Do we need additional decision-making tools in psoriasis?

Mueller SM; Itin PH; Navarini AA; Goldust M; Brandt O; Griffiths CEM; Kleyn CE. . 2020.

The short-term effect of levocetirizine on quality of life, stress, and depression in itchy psoriasis patients.

Mueller SM; Navarini AA; Goldust M; Brandt O; Griffiths CEM; Kleyn CE. . 2020.

Tumoural soft tissue calcification in Down syndrome: association with heterozygous germline SAMD9 mutation and hyperactive type I interferon signaling.

Deigendesch N; Hirsiger JR; Bigler MB; Ghosh A; Harder D; Jauch A; Espinosa JM; Recher M; Navarini A; Daikeler T; Berger CT. Rheumatology (Oxford, England). 2020.

Two-stage pedicled interpolation flap with wings for reconstruction of combined nasal tip/columella defects

Volz A.; Hausermann P.; Navarini A.A.; Volz T.. JDDG - Journal of the German Society of Dermatology. 2020.

Uniparental Disomy of Chromosome 2 Unmasks New ITGA6 Recessive Mutation and Results in a Lethal Junctional Epidermolysis Bullosa in a Newborn.

Higgins R; Jensen AN; Wachstein J; Bruckner-Tuderman L; Spiegel R; Traber H; Achermann J; Schaller M; Fehrenbacher B; Röcken M; Ignatova D; Chang YT; Fischer T; Schwieger-Briel AE; French LE; Hoetzenecker W; Hornung R; Malzacher A; Cozzio A; Navarini A; Has C; Guenova E. ACTA DERMATO-VENEREOLOGICA. 2020.

Update on COVID-19 effects in dermatology specialty.

Goldust M; Kroumpouzos G; Murrell DF; Rudnicka L; Das A; Lotti T; Navarini AA. . 2020.

Utility and risk of dermatologic medications during the COVID-19 pandemic.

Goldust M; Hartmann K; Abdelmaksoud A; Navarini AA. Dermatologic therapy. 2020.

Virtual conferences of dermatology during the COVID-19 pandemic.

Goldust M; Shivakumar S; Kroumpouzos G; Murrell DF; Rudnicka L; Jafferany M; Navarini AA. . 2020.

When life is an itch: What harms, helps, and heals from the patients' perspective? Differences and similarities among skin diseases.

Chee A; Branca L; Jeker F; Vogt DR; Schwegler S; Navarini A; Itin P; Mueller SM. Dermatologic therapy. 2020.

Where do we stand as dermatologists in combat with COVID-19.

Goldust M; Shivakumar S; Kroumpouzos G; Murrell DF; Mueller SM; Navarini AA. . 2020.

[Painful lymphadenopathy after an insect bite-a case report].

Vukovic S; Anagnostopoulos A; Zbinden R; Schönenberger L; Guillod C; French LE; Navarini A; Roider E. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 2019.

[Rosacea - manifestations and treatment options].

Lohbeck A; Anzengruber F; Navarini AA. Therapeutische Umschau. 2019.

Assessment of the impact of sex in intensity, skin flares and central processing of histaminergic itch-A pilot study.

Mueller SM; Mueller F; Reinhardt J; Itin P; Navarini A; Stippich C; Borgwardt S. EXPERIMENTAL DERMATOLOGY. 2019.

Clinical and genetic differences between pustular psoriasis subtypes.

Twelves S; Mostafa A; Dand N; Burri E; Farkas K; Wilson R; Cooper HL; Irvine AD; Oon HH; Kingo K; Köks S; Mrowietz U; Puig L; Reynolds N; Tan ES; Tanew A; Torz K; Trattner H; Valentine M; Wahie S; Warren RB; Wright A; Bata-Csörgő Z; Szell M; Griffiths CEM; Burden AD; Choon SE; Smith CH; Barker JN; Navarini AA; Capon F. The Journal of allergy and clinical immunology. 2019.

Contact dermatitis and sensitization in professional musicians.

Kraft M; Schubert S; Geier J; Worm M; IVDK.. Contact Dermatitis. 2019.

Culprit Drugs Induce Specific IL-36 Overexpression in Acute Generalized Exanthematous Pustulosis.

Meier-Schiesser B; Feldmeyer L; Jankovic D; Mellett M; Satoh TK; Yerly D; Navarini A; Abe R; Yawalkar N; Chung WH; French LE; Contassot E. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2019.

Effectiveness of methotrexate in moderate to severe psoriasis patients: real-world registry data from the Swiss Dermatology Network for Targeted Therapies (SDNTT).

Drach M; Papageorgiou K; Maul JT; Djamei V; Yawalkar N; Häusermann P; Anzengruber F; Navarini AA. ARCHIVES OF DERMATOLOGICAL RESEARCH. 2019.

Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice.

Maul JT; Navarini AA; Sommer R; Anzengruber F; Sorbe C; Mrowietz U; Drach M; Blome C; Boehncke WH; Thaci D; Reich K; von Kiedrowski R; Körber A; Yawalkar N; Mainetti C; Laffitte E; Streit M; Rustenbach S; Conrad C; Borradori L; Gilliet M; Cozzio A; Itin P; Häusermann P; French LE; Radtke MA; Augustin M. Journal of the European Academy of Dermatology and Venereology : JEADV. 2019.

Linkage between patients' characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registry.

Cazzaniga S; Anzengruber F; Augustin M; Boehncke WH; Borradori L; Conrad C; Cozzio A; Djamei V; French LE; Gilliet M; Häusermann P; Heidemeyer K; Itin P; Kolios AGA; Laffitte E; Maul JT; Mainetti C; Naldi L; Navarini AA; Rustenbach SJ; Simon D; Sorbe C; Streit M; Yawalkar N. Journal of the European Academy of Dermatology and Venereology : JEADV. 2019.

Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.

Roth N; Biedermann L; Fournier N; Butter M; Vavricka SR; Navarini AA; Rogler G; Scharl M; Swiss IBD Cohort Study Group.. PLoS One. 2019.

Perspectives of online surveys in dermatology.

Arafa AE; Anzengruber F; Mostafa AM; Navarini AA. Journal of the European Academy of Dermatology and Venereology : JEADV. 2019.


Navarini AA; Smith CH; Barker JN; Capon F. The Journal of allergy and clinical immunology. 2019.

SDHA gain-of-function engages inflammatory mitochondrial retrograde signaling via KEAP1–Nrf2

Burgener A.-V.; Bantug G.R.; Meyer B.J.; Higgins R.; Ghosh A.; Bignucolo O.; Ma E.H.; Loeliger J.; Unterstab G.; Geigges M.; Steiner R.; Enamorado M.; Ivanek R.; Hunziker D.; Schmidt A.; Muller-Durovic B.; Grahlert J.; Epple R.; Dimeloe S.; Lotscher J.; Sauder U.; Ebnother M.; Burger B.; Heijnen I.; Martinez-Cano S.; Cantoni N.; Brucker R.; Kahlert C.R.; Sancho D.; Jones R.G.; Navarini A.; Recher M.; Hess C.. Nature immunology. 2019.

Sex differences in the pharmacology of itch therapies-a narrative review.

Schmid Y; Navarini A; Thomas ZM; Pfleiderer B; Krähenbühl S; Mueller SM. CURRENT OPINION IN PHARMACOLOGY. 2019.

Successful intra-class switching among IL-17 antagonists: a multicentre, multinational, retrospective study.

Gasslitter I; Kirsten N; Augustin M; Torz K; Mrowietz U; Eyerich K; Puig L; Hoetzenecker W; Schütz-Bergmayr M; Weger W; Wolf P; Reider N; Ratzinger G; Papageorgiou K; Meier TO; Maul JT; Anzengruber F; Navarini AA. . 2019.

The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy.

Hedin CRH; Vavricka SR; Stagg AJ; Schoepfer A; Raine T; Puig L; Pleyer U; Navarini A; van der Meulen-de Jong AE; Maul J; Katsanos K; Kagramanova A; Greuter T; González-Lama Y; van Gaalen F; Ellul P; Burisch J; Bettenworth D; Becker MD; Bamias G; Rieder F. Journal of Crohn's and Colitis. 2019.

Thermography: High sensitivity and specificity diagnosing contact dermatitis in patch testing

Anzengruber F.; Alotaibi F.; Kaufmann L.S.; Ghosh A.; Oswald M.R.; Maul J.-T.; Meier B.; French L.E.; Bonmarin M.; Navarini A.A.. Allergology International. 2019.

Tofacitinib for the Treatment of Pyoderma Gangrenosum.

Kochar B; Herfarth N; Mamie C; Navarini AA; Scharl M; Herfarth HH. Clinical Gastroenterology and Hepatology. 2019.

Acne and hidradenitis suppurativa.

Pink A; Anzengruber F; Navarini AA. The British journal of dermatology. 2018.

Autoinflammation behind the curtain.

Navarini AA; French LE. The British journal of dermatology. 2018.

Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel Disease.

Vavricka SR; Galván JA; Dawson H; Soltermann A; Biedermann L; Scharl M; Schoepfer AM; Rogler G; Prinz Vavricka MB; Terracciano L; Navarini A; Zlobec I; Lugli A; Greuter T. Journal of Crohn's and Colitis. 2018.

Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review.

Boehner A; Navarini AA; Eyerich K. EXPERIMENTAL DERMATOLOGY. 2018.

Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acne.

Petridis C; Navarini AA; Dand N; Saklatvala J; Baudry D; Duckworth M; Allen MH; Curtis CJ; Lee SH; Burden AD; Layton A; Bataille V; Pink AE; Acne Genetic Study Group.; Carlavan I; Voegel JJ; Spector TD; Trembath RC; McGrath JA; Smith CH; Barker JN; Simpson MA. Nature Communications. 2018.

Paradoxical ulcerative colitis during adalimumab treatment of psoriasis resolved by switch to ustekinumab.

Kolios AGA; Biedermann L; Weber A; Navarini AA; Meier J; Cozzio A; French LE. The British journal of dermatology. 2018.

Praxis der Teledermatologie.

Augustin M; Wimmer J; Biedermann T; Blaga R; Dierks C; Djamei V; Elmer A; Elsner P; Enk A; Gass S; Henningsen M; Hofman-Wellenhof R; von Kiedrowski R; Kunz HD; Liebram C; Navarini A; Otten M; Reusch M; Schüller C; Zink A; Strömer K. JDDG - Journal of the German Society of Dermatology. 2018.


Navarini, Alexander A.. . 2018.

Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation.

Hartwig T; Zwicky P; Schreiner B; Yawalkar N; Cheng P; Navarini A; Dummer R; Flatz L; Conrad C; Schlapbach C; Becher B. Cell Reports. 2018.

Survival of Second-Line Biologics in Psoriasis: The British BADBIR Registry Data Informs Daily Practice.


Therapy response was not altered by HLA-Cw6 status in psoriasis patients treated with secukinumab: a retrospective case series.

Anzengruber F; Drach M; Maul JT; Kolios AG; Meier B; Navarini AA. Journal of the European Academy of Dermatology and Venereology : JEADV. 2018.

TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis.

Conrad C; Di Domizio J; Mylonas A; Belkhodja C; Demaria O; Navarini AA; Lapointe AK; French LE; Vernez M; Gilliet M. Nature Communications. 2018.

TNFα and IL-17A are differentially expressed in psoriasis-like vs eczema-like drug reactions to TNFα antagonists.

Deubelbeiss C; Kolios AGA; Anzengruber F; French LE; Yawalkar N; Kempf W; Kerl K; Meier B; Navarini AA. JOURNAL OF CUTANEOUS PATHOLOGY. 2018.

Unmet digital health service needs in dermatology patients.

Greis C; Meier Zürcher C; Djamei V; Moser A; Lautenschlager S; Navarini AA. The Journal of dermatological treatment. 2018.

Wide range of age of onset and low referral rates to psychiatry in a large cohort of acne excoriée at a Swiss tertiary hospital.

Anzengruber F; Ruhwinkel K; Ghosh A; Klaghofer R; Lang UE; Navarini AA. The Journal of dermatological treatment. 2018.

A case of tinea incognita and differential diagnosis of figurate erythema.

Maul JT; Maier PW; Anzengruber F; Murer C; Bosshard PP; Kerl K; French LE; Navarini AA. Medical mycology case reports. 2017.

Acne and Telomere Length: A New Spectrum between Senescence and Apoptosis Pathways.

Ribero S; Sanna M; Visconti A; Navarini A; Aviv A; Glass D; Spector TD; Smith C; Simpson M; Barker J; Mangino M; Falchi M; Bataille V. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2017.

Allergic Contact Dermatitis.

Kostner L; Anzengruber F; Guillod C; Recher M; Schmid-Grendelmeier P; Navarini AA. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA. 2017.

A Report of Two Cases of Solid Facial Edema in Acne.

Kuhn-Régnier S; Mangana J; Kerl K; Kamarachev J; French LE; Cozzio A; Navarini AA. Dermatology and Therapy. 2017.

Clinical Disease Patterns in a Regional Swiss Cohort of 34 Pyoderma Gangrenosum Patients.

Kolios AGA; Gübeli A; Meier B; Maul JT; Kündig T; Nilsson J; Hafner J; Guenova E; Kerl K; Anliker M; Kempf W; Navarini AA; French LE; Cozzio A. Dermatology (Basel, Switzerland). 2017.

Detection of Sp110 by Flow Cytometry and Application to Screening Patients for Veno-occlusive Disease with Immunodeficiency.

Marquardsen FA; Baldin F; Wunderer F; Al-Herz W; Mikhael R; Lefranc G; Baz Z; Rezaee F; Hanna R; Kfir-Erenfeld S; Stepensky P; Meyer B; Jauch A; Bigler MB; Burgener AV; Higgins R; Navarini AA; Church JA; Chou J; Geha R; Notarangelo LD; Hess C; Berger CT; Bloch DB; Recher M. Journal of clinical immunology. 2017.

European consensus statement on phenotypes of pustular psoriasis.

Navarini AA; Burden AD; Capon F; Mrowietz U; Puig L; Köks S; Kingo K; Smith C; Barker JN; ERASPEN Network.. Journal of the European Academy of Dermatology and Venereology : JEADV. 2017.

Generalized Comedones, Acne, and Hidradenitis Suppurativa in a Patient with an <i>FGFR2</i> Missense Mutation.

Higgins R; Pink A; Hunger R; Yawalkar N; Navarini AA. Frontiers in Medicine. 2017.

Genetic architecture of acne vulgaris.

Lichtenberger R; Simpson MA; Smith C; Barker J; Navarini AA. Journal of the European Academy of Dermatology and Venereology : JEADV. 2017.

Impact of UVA on pruritus during UVA/B phototherapy of inflammatory skin diseases: a randomized double-blind study.

Maul JT; Kretschmer L; Anzengruber F; Pink A; Murer C; French LE; Hofbauer GF; Navarini AA. Journal of the European Academy of Dermatology and Venereology : JEADV. 2017.

Interruption of Sneddon-Wilkinson Subcorneal Pustulation with Infliximab.

Kretschmer L; Maul JT; Hofer T; Navarini AA. Case reports in dermatology. 2017.

Limited clinical utility of HLA-Cw6 genotyping for outcome prediction in psoriasis patients under ustekinumab therapy: a monocentric, retrospective analysis.

Anzengruber F; Ghosh A; Maul JT; Drach M; Navarini AA. Psoriasis (Auckland, N.Z.). 2017.

Low immunoglobulin E flags two distinct types of immune dysregulation.

Elkuch M; Greiff V; Berger CT; Bouchenaki M; Daikeler T; Bircher A; Navarini AA; Heijnen I; Recher M. Clinical and experimental immunology. 2017.

Pustuloses amicrobiennes

Navarini, A; Borradori, L; Saurat J.-H.. . 2017.

Rapid Involution of Pustules during Topical Steroid Treatment of Acute Generalized Exanthematous Pustulosis.

Kley C; Murer C; Maul JT; Meier B; Anzengruber F; Navarini AA. Case reports in dermatology. 2017.

Secukinumab for Acrodermatitis Continua of Hallopeau.

Muggli D; Maul JT; Anzengruber F; Fopp MW; Navarini AA. JAMA dermatology. 2017.

Skin Manifestations of Inflammatory Bowel Disease.

Greuter T; Navarini A; Vavricka SR. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. 2017.

Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa.

Hunger RE; Laffitte E; Läuchli S; Mainetti C; Mühlstädt M; Schiller P; Lapointe AK; Meschberger P; Navarini AA. Dermatology (Basel, Switzerland). 2017.

Swiss S1 guideline for the treatment of rosacea.

Anzengruber F; Czernielewski J; Conrad C; Feldmeyer L; Yawalkar N; Häusermann P; Cozzio A; Mainetti C; Goldblum D; Läuchli S; Imhof L; Brand C; Laffitte E; Navarini AA. Journal of the European Academy of Dermatology and Venereology : JEADV. 2017.

Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis.

Navarini AA; Hruz P; Berger CT; Hou TZ; Schwab C; Gabrysch A; Higgins R; Frede N; Padberg Sgier BC; Kämpe O; Burgener AV; Marquardsen F; Baldin F; Bigler M; Kistner A; Jauch A; Bignucolo O; Meyer B; Meienberg F; Mehling M; Jeker LT; Heijnen I; Daikeler TD; Gebbers JO; Grimbacher B; Sansom DM; Jeker R; Hess C; Recher M. The Journal of allergy and clinical immunology. 2017.

White Scale Sign for Xeroderma.

Klemmer A; Anzengruber F; Kazakov D; Navarini AA. JAMA dermatology. 2017.

Apremilast Is Effective in Lichen Planus Mucosae-Associated Stenotic Esophagitis.

Hafner J; Gubler C; Kaufmann K; Nobbe S; Navarini AA; French LE. . 2016.

Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTT.

Maul JT; Djamei V; Kolios AGA; Meier B; Czernielewski J; Jungo P; Yawalkar N; Mainetti C; Laffitte E; Spehr C; Anliker M; Streit M; Augustin M; Rustenbach S; Conrad C; Hafner J; Boehncke WH; Borradori L; Gilliet M; Itin P; French LE; Häusermann P; Navarini AA. Dermatology (Basel, Switzerland). 2016.

Expression of CD164 on Malignant T cells in Sézary Syndrome.

Guenova E; Ignatova D; Chang YT; Contassot E; Mehra T; Saulite I; Navarini AA; Mitev V; Dummer R; Kazakov DV; French LE; Hoetzenecker W; Cozzio A. ACTA DERMATO-VENEREOLOGICA. 2016.

Neutrophilic dermatoses and autoinflammatory diseases with skin involvement--innate immune disorders.

Navarini AA; Satoh TK; French LE. Seminars in Immunopathology. 2016.

Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis Registry.

Jungo P; Maul JT; Djamei V; von Felten S; Kolios AGA; Czernielewsk J; Yawalkar N; Odermatt O; Laffitte E; Anliker M; Streit M; Augustin M; Conrad C; Hafner J; Boehncke WH; Gilliet M; Itin P; French LE; Navarini AA; Häusermann P. Dermatology (Basel, Switzerland). 2016.

Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris.

Kolios AG; Yawalkar N; Anliker M; Boehncke WH; Borradori L; Conrad C; Gilliet M; Häusermann P; Itin P; Laffitte E; Mainetti C; French LE; Navarini AA. Dermatology (Basel, Switzerland). 2016.

Targeting CD8(+) T cells prevents psoriasis development.

Di Meglio P; Villanova F; Navarini AA; Mylonas A; Tosi I; Nestle FO; Conrad C. . 2016.

The continuing evolution of targeted therapy for inflammatory skin disease.

Schlapbach C; Navarini AA. Seminars in Immunopathology. 2016.

The skin and its blossoms--fertile soil for clinical science.

Navarini AA; French LE. . 2016.

Transient Efficacy of Tofacitinib in Alopecia Areata Universalis.

Anzengruber F; Maul JT; Kamarachev J; Trüeb RM; French LE; Navarini AA. . 2016.

Worsening of Lymphopenia during Apremilast Treatment.

Kolios AG; French LE; Navarini AA. . 2016.

Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris.

Berki DM; Liu L; Choon SE; David Burden A; Griffiths CEM; Navarini AA; Tan ES; Irvine AD; Ranki A; Ogo T; Petrof G; Mahil SK; Duckworth M; Allen MH; Vito P; Trembath RC; McGrath J; Smith CH; Capon F; Barker JN. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2015.

Beauty and the Biologic: Artistic Documentation of Scientific Breakthrough in Psoriasis.

Maul JT; Carraro S; Stierlin J; Geiges ML; Navarini AA. . 2015.

Canakinumab in adults with steroid-refractory pyoderma gangrenosum.

Kolios AG; Maul JT; Meier B; Kerl K; Traidl-Hoffmann C; Hertl M; Zillikens D; Röcken M; Ring J; Facchiano A; Mondino C; Yawalkar N; Contassot E; Navarini AA; French LE. . 2015.

Complement Regulates Nutrient Influx and Metabolic Reprogramming during Th1 Cell Responses.

Kolev M; Dimeloe S; Le Friec G; Navarini A; Arbore G; Povoleri GA; Fischer M; Belle R; Loeliger J; Develioglu L; Bantug GR; Watson J; Couzi L; Afzali B; Lavender P; Hess C; Kemper C. Immunity. 2015.

Extraintestinal Manifestations of Inflammatory Bowel Disease.

Vavricka SR; Schoepfer A; Scharl M; Lakatos PL; Navarini A; Rogler G. Inflammatory Bowel Diseases. 2015.

Homozygous missense mutation in IL36RN in generalized pustular dermatosis with intraoral involvement compatible with both AGEP and generalized pustular psoriasis.

Navarini AA; Simpson MA; Borradori L; Yawalkar N; Schlapbach C. JAMA dermatology. 2015.

Severe Sweet's Syndrome with Elevated Cutaneous Interleukin-1β after Azathioprine Exposure: Case Report and Review of the Literature.

Imhof L; Meier B; Frei P; Kamarachev J; Rogler G; Kolios A; Navarini AA; Contassot E; French LE. Dermatology (Basel, Switzerland). 2015.

Virus-Induced Type I Interferon Deteriorates Control of Systemic Pseudomonas Aeruginosa Infection.

Merches K; Khairnar V; Knuschke T; Shaabani N; Honke N; Duhan V; Recher M; Navarini AA; Hardt C; Häussinger D; Tümmler B; Gulbins E; Futerman AH; Hoffmann D; Lang F; Lang PA; Westendorf AM; Lang KS. Cellular Physiology and Biochemistry. 2015.

Personalisierte Medizin

Eckhardt, Anne; Navarini, Alexander A.; Recher, Alecs; Rippe, Klaus Peter; Rütsche, Bernhard; Telser, Harry; Marti, Michèle. . 2014.

Canities subita: a reappraisal of evidence based on 196 case reports published in the medical literature.

Nahm M; Navarini AA; Kelly EW. International journal of trichology. 2013.

Oral, esophageal and cutaneous lichen ruber planus controlled with alitretinoin: case report and review of the literature.

Kolios AG; Marques Maggio E; Gubler C; Cozzio A; Dummer R; French LE; Navarini AA. Dermatology (Basel, Switzerland). 2013.

Unexplained recurrent fever: when is autoinflammation the explanation?

Kallinich T; Gattorno M; Grattan CE; de Koning HD; Traidl-Hoffmann C; Feist E; Krause K; Lipsker D; Navarini AA; Maurer M; Lachmann HJ; Simon A. Allergy. 2013.

Hematopoietic cell-derived interferon controls viral replication and virus-induced disease.

Lang PA; Cervantes-Barragan L; Verschoor A; Navarini AA; Recher M; Pellegrini M; Flatz L; Bergthaler A; Honda K; Ludewig B; Ohashi PS; Lang KS. Blood. 2009.

Innate immune-induced depletion of bone marrow neutrophils aggravates systemic bacterial infections.

Navarini AA; Lang KS; Verschoor A; Recher M; Zinkernagel AS; Nizet V; Odermatt B; Hengartner H; Zinkernagel RM. Proceedings of the National Academy of Sciences of the United States of America. 2009.

Marie Antoinette syndrome.

Navarini AA; Nobbe S; Trüeb RM. ARCHIVES OF DERMATOLOGY. 2009.

Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model.

Tun-Kyi A; Qin JZ; Oberholzer PA; Navarini AA; Hassel JC; Dummer R; Döbbeling U. Annals of oncology : official journal of the European Society for Medical Oncology. 2008.

Cholestasis protects the liver from ischaemic injury and post-ischaemic inflammation in the mouse.

Georgiev P; Navarini AA; Eloranta JJ; Lang KS; Kullak-Ublick GA; Nocito A; Dahm F; Jochum W; Graf R; Clavien PA. Gut. 2007.

Extralymphatic virus sanctuaries as a consequence of potent T-cell activation.

Recher M; Lang KS; Navarini A; Hunziker L; Lang PA; Fink K; Freigang S; Georgiev P; Hangartner L; Zellweger R; Bergthaler A; Hegazy AN; Eschli B; Theocharides A; Jeker LT; Merkler D; Odermatt B; Hersberger M; Hengartner H; Zinkernagel RM. Nature medicine. 2007.

Induced prion protein controls immune-activated retroviruses in the mouse spleen.

Lötscher M; Recher M; Lang KS; Navarini A; Hunziker L; Santimaria R; Glatzel M; Schwarz P; Böni J; Zinkernagel RM. PLoS One. 2007.

MyD88 protects from lethal encephalitis during infection with vesicular stomatitis virus.

Lang KS; Navarini AA; Recher M; Lang PA; Heikenwalder M; Stecher B; Bergthaler A; Odermatt B; Akira S; Honda K; Hengartner H; Zinkernagel RM. European journal of immunology. 2007.

Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses.

Navarini AA; Recher M; Lang KS; Georgiev P; Meury S; Bergthaler A; Flatz L; Bille J; Landmann R; Odermatt B; Hengartner H; Zinkernagel RM. Proceedings of the National Academy of Sciences of the United States of America. 2006.